Propyl chloroformate

We are Propyl chloroformate CAS:109-61-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Propyl chloroformate
CAS.NO:109-61-5
Synonyms:Propyl chloroformate
Chloroformic Acid Propyl Ester
Carbonochloridic acid, propyl ester
propyl carbonochloridate
Chloroformicacidpropylester
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 116.2±9.0 °C at 760 mmHg
Melting Point <-70ºC
Molecular Formula C4H7ClO2
Molecular Weight 122.550
Flash Point 28.9±0.0 °C
Vapour Pressure 18.4±0.2 mmHg at 25°C
Index of Refraction 1.412
 
Specification:
Appearance:Colorless to light yellow transparent liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Propamocarb(CAS:24579-73-5).

Propyl chloroformate


Related News: Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.5-Fluoro-2-nitrobenzadehyde By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.L-alpha-Amino-n-butyric acid CAS:1492-24-6 Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.Dimethoxydiphenylsilane CAS:6843-66-9 The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.

Related Products
Product Name
ethyl isothiocyanate View Details
triethoxy(propyl)silane View Details
2-(TRIFLUOROMETHYL)PHENYL ISOTHIOCYANATE View Details
Methyl pivaloylacetate manufacturer 1,3-dichloro-2-methoxybenzene manufacturer N-Methyl acetoacetamide manufacturer 5′-inosinic acid disodium salt hydrate manufacturer 4-(4-bromo-3-(hydroxyMethyl)phenoxy)benzonitrile manufacturer